Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes-Reference-Cited by-同舟云学术

Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes

Published:2002-10-25 Issue:9 Volume:95 Page:1923-1930
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Aguayo Alvaro,Kantarjian Hagop M.,Estey Elihu H.,Giles Francis J.,Verstovsek Srdan,Manshouri Taghi,Gidel Christy,O'Brien Susan,Keating Michael J.,Albitar Maher

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference59 articles.

1. Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen

2. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma

3. Elevated Levels of an Angiogenic Peptide, Basic Fibroblast Growth Factor, in the Urine of Patients With a Wide Spectrum of Cancers

4. Basic Fibroblast Growth Factor: A Missing Link between Collagen VII, Increased Collagenase, and Squamous Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic and leukemic stem cells homeostasis: the role of bone marrow niche;Exploration of Targeted Anti-tumor Therapy;2024-08-15

2. Molecular Pathogenesis and Treatment Strategies of Chronic Myeloid Leukemia (CML);Sudan Journal of Medical Sciences;2023-12-29

3. Changes in serum basic fibroblast growth factor concentration following intracordal injection;Laryngoscope Investigative Otolaryngology;2023-02-21

4. Evaluation of VEGF and VEGFR gene expression as prognostic markers in low and intermediate‑1 risk patients with myelodysplastic syndromes;Oncology Letters;2023-01-26

5. A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy;Annals of Hematology;2022-11-18